AMS would like to congratulate AMS and IMS Past-President Professor Susan Davis on being awarded an Officer (AO) in the General Division for distinguished service of a high degree to Australia or humanity at large.

Sue was awarded the Australia Day Honour for distinguished service to medicine, to women's health as a clinical endocrinologist and researcher, and to medical education.

Many of you would know how tirelessly Sue has worked in women’s health and particularly in menopause education and research.

Congratulation Sue on your award, which is most deserving.

There has been a recent shortage of a number of menopausal hormone therapy (MHT) preparations and some of these have now been or soon will be resolved:

Oral MHT

Femoston 1/10 – resolved

Duavive – supply due to be resolved by end January 2022

Angeliq - resolved 

Transdermal

Climara – resolved

Estradot 100 – resolved

Estradot 75 – supply due to be resolved by the early April

Estradot 50 – supply due to be resolved by the early February

Estradot 37.5 – supply due to be resolved by early April

Estradot 25 – resolved

Estalis Conti - resolved

Estalis Sequi 50/140 –supply due to be resolved by mid February

Estalis Sequi 50/250 –supply due to be resolved by mid February

Estraderm MX 50 – supply due to be resolved by end of April

Estraderm MX 100 - supply due to be resolved by end of April 

Estrogel/Estrogel Pro – resolved

Please note that dates for supply have been sourced from either the pharmaceutical distributor or the TGA website and may change at any time.